Valeo Pharma Inc. (VPHIF)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Oct 17, 2025
Valeo Pharma Market Cap
Valeo Pharma has a market cap or net worth of $29.6 thousand as of October 21, 2025. Its market cap has decreased by -99.94% in one year.
Market Cap
29.60K
Enterprise Value
46.07M
Revenue
38.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 23, 2020, Valeo Pharma's market cap has decreased from 53.11M to 29.60K, a decrease of -99.94%. That is a compound annual growth rate of -77.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 29.60K | -99.79% |
| Dec 29, 2023 | 13.81M | -59.55% |
| Dec 29, 2022 | 34.15M | -24.96% |
| Dec 31, 2021 | 45.51M | -27.02% |
| Dec 31, 2020 | 62.37M | 17.42% |
| Sep 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Glass House Brands | 663.09M |
| Elite Pharmaceuticals | 636.35M |
| Northwest Biotherapeutics | 340.56M |
| Silence Therapeutics | 339.61M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 326.28M |
| American Oncology Network | 293.21M |